The dose of granulocyte-colony- stimulating factor after chemopriming treatment does not influence apheresis yield of progenitor cells: A retrospective study of 91 cases

Transfusion

Volumn 39, Issue 11-12, 1999, Pages 1207-1211

  Lefrere F ^a   Belanger, C ^a   Audat, F ^a   Hermine, O ^a   Cavazzana Calvo, M ^a   Arnulf, B ^a   Buzyn, A ^a   Varet, B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LEUKEMIA; ADULT; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOTHERAPY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA;

ADULT; ANTIGENS, CD34; BLOOD CELL COUNT; BLOOD SPECIMEN COLLECTION; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELLS;

EID: 0032756735     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39111207.x     Document Type: Article

References (16)

1. Kessinger A, Armitage JO, Landmark JD, et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-7.
2. Hohaus S, Goldschmit H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993;21:508-14.
3. Chao NJ, Schriber JR, Grimes K, et al. Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993;81:2031-5.
4. Siena S, Bregni M, Brando M, et al. Circulation of CD34+ haematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor. Blood 1989;74:1905-14.
5. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-55.
6. Martin-Murea S, Voso MT, Hohaus S, et al. The dose of granulocyte colony-stimulating factor administered following cytotoxic chemotherapy is not related to the rebound level of circulating CD34+ haematopoietic progenitor cells during marrow recovery. Br J Haematol 1998;101:582-5.
7. Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral blood stem cell after mobilization therapy: prediction of CD34+ yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996;14:970-3.
8. Haas R, Mohle R, Fruhauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
9. Hartmann LC, Tschetter LJ, Habermann TM, et al. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med 1997;336:1776-80.
10. Bolwell B, Goormastic M, Dannley R, et al. G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10 and 16 micrograms/kg/day. Bone Marrow Transplant 1997;19:215-9.
11. McQuaker I, Hunter AE, Pacey S, et al. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol 1997;15:451-7.
12. Toner GC, Shapiro JD, Laidlaw CR, et al. Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison. J Clin Oncol 1998;16:3874-9.
13. Hoglund M, Smedmyr B, Simonsson B, et al. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 1996;18:19-27.
14. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996;36:601-10.
15. Faulkner LB, Tucci F, Tamburini A, et al. G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective. Bone Marrow Transplant 1998;21:1091-5.
16. Lefrere F, Audat F, Hermine O, et al. The timing of granulocyte-colony-stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 cases. Transfusion 1999;39:561-4.